A Broad Analysis of the “Global Live Cell Imaging Market Research Report- Forecast To 2022 “methodology of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the industry performance.
Live Cell Imaging Market – Overview
Live Cell Imaging is a technique to study live cells with the help of images obtained with imaging systems such as microscopes and high content screening systems.
Over the past few years, the adoption of high content screening techniques in drug discovery and cell biology has been continuously rising and so is growing the live cell imaging market.
As a result, live cell imaging is pervasively gaining a considerable prominence, and its market is garnering colossal accruals. Moreover, the factors such as the increasing prevalence of chronic diseases and growing government funding in cell-based research are escalating the market on the global heights.
GET PREMIUM SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/6075
Leading Industry Key Players
Leica Microsystems (Germany)
Carl Zeiss AG (Germany)
Olympus Corporation (Japan)
Nikon Corporation (Japan)
Sigma-Aldrich Corporation (U.S.)
Molecular Devices, LCC (U.S.)
GE Healthcare (U.K.)
PerkinElmer, Inc. (U.S.)
Dickinson and Company (U.S.)
Detailed Market Segment Analysis
Global perfusion market has been segmented on the basis of type which comprise of cardiopulmonary bypass, extracorporeal membrane oxygenation, isolated limb perfusion and others.
Cardiopulmonary bypass is further sub-segmented into heart-lung machines, oxygenators, perfusion pumps, monitoring systems, cannulas, and other components.
On the basis of application, it is segmented into lungs, heart, liver, kidneys and others. On the basis of device type, the market has been segmented into hypothermic machine perfusion, normothermic machine perfusion and others.
On the basis of end user, it is segmented into hospital, specialty clinics, medical research centers, academic institutes, and others.
Live Cell Imaging Market – Growth and Analysis
Acknowledging the exponential accruals, the market is witnessing currently, Market Research Future (MRFR), in its recently published study report, asserts that the global live cell imaging market will register approximately 9 % CAGR between 2018 -2023, garnering impressive growth by 2023.
Additional factors driving the market growth include the various applications of live cell imaging in the biotech and pharmaceutical industry and the rising prevalence of cancer worldwide.
Furthermore, increasing approvals from regulatory bodies and spreading awareness foster the market growth.
The increasing number of research activities in the pharmaceutical manufacturing and bioscience defines the augmented demand for live cell imaging and its increasing market size.
On the flip side, factors such as the lack of availability of skilled professional and the prohibitive costs associated with the high-content screening systems are some of the primary factors that are impeding the market growth.
Nevertheless, the support rendered by developed countries in terms of funding and well-established market players is projected to support the market growth.
BROWSE PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/live-cell-imaging-market-6075
Global Live Cell Imaging Market- Regional Analysis
The North American region dominates the global live cell imaging market with substantial investments made into R&D activities in the biotech and pharmaceutical sectors.
Strong economic conditions in the region fuel the market growth, allowing funding required for research and development. Moreover, the presence of giant players is impacting the market growth in the region, positively.
The European region heading with the increased focus on research and development, especially in the biotechnology sector, accounts for another lucrative market for live cell imaging.
Also, the presence of some of the notable players such as Leica Microsystems, Carl Zeiss AG, and GE Healthcare facilitates the market growth in the region.
The Asia Pacific live cell imaging market is rapidly emerging as a promising market. The increasing number of research labs define the market landscape in the region.
Japan among other APAC countries accounts for the largest market for live cell imaging due to the increase in the prevalence of cancer and demand for live cell imaging techniques.
Whereas, in China, factors such as rising geriatric population with chronic diseases and the availability of low-cost diagnostic and treatment options drive the market growth.
Global Live Cell Imaging Market- Competitive Analysis
The competitive market of live cell imaging appears fragmented owing to the many large and small players along with the new entrants churning the competition.
Due to the high growth potential and demand in the market; players also plan to increase production of the products used in the cell culture.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312